BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Top 5 Massachusetts Biotechs That Jumped at Least 250% in 2017

  Boston Business Journal pulled together a list of the 25 biggest gainers in the state for 2017, and five of them are biopharma companies.

  December 11, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Tax Reform: A War on Life Sciences Innovation

  One of the biggest concerns has been the loss of the R&D tax credit, which incentivizes companies, including life science firms, to support research.

  December 11, 2017

   · 

  2 min read

   · 

  Josh Baxt, BioSpace Contributor
• 

  Job Trends

  New York’s Koning Picks Atlanta for New HQ, Will Create Up to 400 New Jobs

  Koning has selected Atlanta for its new headquarters and intends to open a new 100,000 square foot facility there.

  December 11, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Mako Medical to Create 153 Jobs in North Carolina Expansion

  The expansion will nearly double its employment.

  December 11, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Intuitive Surgical Pays $274M to Goldman Sach, Closes $2B Share Buyback Deal

  The payback was part of a total $3 billion stock repurchasing deal the company initiated on January 27.

  December 11, 2017

   · 

  1 min read
• Deals

  China Investor Syndicate Acquires Esaote, an Italian Imaging Device Company

  Esaote S.p.A., an Italian medical imaging company, has been acquired by a group of China investors.

  December 11, 2017

   · 

  1 min read
• Business

  Week in Review: China Life Science Deals Total $550M

  Pfizer acquired China/Asia rights for Cresemba, an antifungal drug developed by Swiss pharma Basilea, in a $226M deal.

  December 11, 2017

   · 

  1 min read
• 

  BioMidwest

  Astellas Pharma Exec Shares His Best Life Science Career Advice

  Johnston joined Astellas in 2008 as vice president, marketing and new product planning.

  December 11, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About Corbin Therapeutics

  Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem.

  December 11, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Debt-Ridden Teva Considers Cutting Up to 10,000 Jobs

  Teva may be passing out more pink slips as the company looks to cut up to 10,000 jobs in order to save up to $2B in costs over the next two years.

  December 11, 2017

   · 

  2 min read

   · 

  Alex Keown